Infographic: Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE)

Affiliations

• ¹ UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK. n.wijesingha@nhs.net.
• ² NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK. n.wijesingha@nhs.net.
• ³ UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
• ⁴ NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.